TR201818784T4 - Selenyum İle Kombinasyon Halinde Aronia Sp.'nin Bir Ekstraktını İçeren Bağışık Uyarıcı Terkip - Google Patents
Selenyum İle Kombinasyon Halinde Aronia Sp.'nin Bir Ekstraktını İçeren Bağışık Uyarıcı Terkip Download PDFInfo
- Publication number
- TR201818784T4 TR201818784T4 TR2018/18784T TR201818784T TR201818784T4 TR 201818784 T4 TR201818784 T4 TR 201818784T4 TR 2018/18784 T TR2018/18784 T TR 2018/18784T TR 201818784 T TR201818784 T TR 201818784T TR 201818784 T4 TR201818784 T4 TR 201818784T4
- Authority
- TR
- Turkey
- Prior art keywords
- selenium
- combination
- aronia
- extract
- composition containing
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 5
- 241001444063 Aronia Species 0.000 title abstract 2
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 title abstract 2
- 239000011669 selenium Substances 0.000 title abstract 2
- 229910052711 selenium Inorganic materials 0.000 title abstract 2
- 230000003308 immunostimulating effect Effects 0.000 title 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 abstract 1
- 210000000987 immune system Anatomy 0.000 abstract 1
- 239000002417 nutraceutical Substances 0.000 abstract 1
- 235000021436 nutraceutical agent Nutrition 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
- 239000011701 zinc Substances 0.000 abstract 1
- 229910052725 zinc Inorganic materials 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pulmonology (AREA)
- Inorganic Chemistry (AREA)
- Communicable Diseases (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Oncology (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Ophthalmology & Optometry (AREA)
- Dermatology (AREA)
- Virology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Cardiology (AREA)
Abstract
Mevcut buluş, immün sistemin uyarılması için Aronia ekstraktı ile selenyum, çinko ve bunların kombinasyonlarını içeren bir gruptan seçilen bir mikrobesinin bir kombinasyonunu içeren bir terkibe ilişkindir. Söz konusu terkip ayrıca, farmasötik olarak kabul edilebilir nitelikte olan en az bir eksipiyan veya farmasötik olarak kabul edilebilir nitelikte olan eksipiyanlardan meydana gelen bir karışımı içerebilmekte olup, farmasötik veya nutrasötik bir terkip olarak formüle edilebilmektedir.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09006414A EP2260856A1 (en) | 2009-05-12 | 2009-05-12 | Immune stimulating composition comprising an extract of aronia sp. in combination with selenium and/or zinc |
Publications (1)
Publication Number | Publication Date |
---|---|
TR201818784T4 true TR201818784T4 (tr) | 2019-01-21 |
Family
ID=41228588
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2018/18784T TR201818784T4 (tr) | 2009-05-12 | 2010-05-06 | Selenyum İle Kombinasyon Halinde Aronia Sp.'nin Bir Ekstraktını İçeren Bağışık Uyarıcı Terkip |
Country Status (14)
Country | Link |
---|---|
US (2) | US20120148683A1 (tr) |
EP (2) | EP2260856A1 (tr) |
JP (1) | JP5612670B2 (tr) |
CN (2) | CN102421446A (tr) |
CA (1) | CA2757759C (tr) |
CY (1) | CY1121268T1 (tr) |
DK (1) | DK2429560T3 (tr) |
ES (1) | ES2704025T3 (tr) |
LT (1) | LT2429560T (tr) |
MX (1) | MX347299B (tr) |
PL (1) | PL2429560T3 (tr) |
PT (1) | PT2429560T (tr) |
TR (1) | TR201818784T4 (tr) |
WO (1) | WO2010130629A1 (tr) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2013138633A (ja) * | 2011-12-28 | 2013-07-18 | Pola Chemical Industries Inc | 液状食品組成物の澱発生防止方法 |
CN103417668A (zh) * | 2013-07-29 | 2013-12-04 | 辽宁大学 | 西伯利亚花楸果实提取物在制备抗HeLa癌细胞的药品或保健品中的应用 |
CN105434465B (zh) * | 2015-12-14 | 2019-07-16 | 米军 | 一种防治关节炎的药物组合物及其制备方法 |
CN111565758A (zh) * | 2017-10-27 | 2020-08-21 | 株式会社张峰根研究所 | 包含花色素苷-岩藻依聚糖复合物为活性成分的免疫增强剂、免疫治疗抗癌剂和抗癌治疗不良反应缓解剂 |
US10568866B1 (en) * | 2018-10-05 | 2020-02-25 | Matthias W. Rath | Composition and its use for increasing innate immune health |
CN109248202A (zh) * | 2018-11-14 | 2019-01-22 | 吉林大学 | 一种花楸果及其提取物在制备抗病毒性肝炎药物中的应用 |
CN115105527A (zh) * | 2022-07-01 | 2022-09-27 | 湖北省疾病预防控制中心(湖北省预防医学科学院) | 药物组合物及其用途 |
CN116270822B (zh) * | 2023-04-21 | 2024-03-15 | 广东冠清柠生物科技有限公司 | 一种缓解肺部纤维化的植物提取物及其制备方法和应用 |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5300288A (en) * | 1991-04-05 | 1994-04-05 | Rohm And Haas Company | Composition and method for controlling cholesterol |
EP1005863A1 (en) * | 1998-12-04 | 2000-06-07 | Synthelabo | Controlled-release dosage forms comprising a short acting hypnotic or a salt thereof |
CN1384713A (zh) | 1999-08-27 | 2002-12-11 | 密执安州大学 | 包含天然的环加氧酶抑制剂的保健食品添加剂 |
AU2001276462A1 (en) | 2000-07-18 | 2002-01-30 | Forum Bioscience | Use of natural products in cancer treatment |
US6703056B2 (en) | 2000-09-29 | 2004-03-09 | The Procter + Gamble Co. | Beverage compositions comprising arabinogalactan and defined minerals |
RU2236244C2 (ru) * | 2001-12-27 | 2004-09-20 | Тулев Юрий Владимирович | Иммунотропный препарат "витулин в" |
DE102004029887A1 (de) | 2003-06-23 | 2005-01-20 | Norbert Groth | Nahrungsergänzungsmittel auf Tresterbasis |
US20050129825A1 (en) | 2003-12-16 | 2005-06-16 | Gray Kimberley H. | Stabilization of milk-based products |
JP2005213242A (ja) * | 2004-02-02 | 2005-08-11 | Shonan Institute For Medical & Preventive Science | シクロオキシゲナーゼ及び誘導型一酸化窒素合成酵素の阻害剤及び食品 |
JP4247833B2 (ja) * | 2004-03-16 | 2009-04-02 | 株式会社ケーツーコミュニケーションズ | 視機能改善剤 |
US7964234B2 (en) * | 2004-10-28 | 2011-06-21 | Neways, Inc. | High mineral content dietary supplement |
DE102004052882A1 (de) | 2004-11-02 | 2006-05-04 | Ihv Internationale Handels- Und Vertriebsgesellschaft Mbh | Nahrungsergänzungsmittel und Herstellungsverfahren dafür |
US20070020358A1 (en) | 2005-03-18 | 2007-01-25 | Mower Thomas E | Sports drink concentrate |
US7749545B2 (en) * | 2005-03-18 | 2010-07-06 | Sakura Properties, Llc | Fucoidan compositions and methods for dietary and nutritional supplements |
US20060286207A1 (en) | 2005-06-14 | 2006-12-21 | Gray Kimberley H | Stabilization of malt-based and hops-based products |
DE102005046474A1 (de) | 2005-07-15 | 2007-01-18 | Norbert Groth | Verwendung eines Schalenextraktes aus Aronia sp. als antibakterielles, antimykotisches und entzündungshemmendes Mittel |
FR2892933B1 (fr) | 2005-11-10 | 2010-11-05 | Herve Andre Gerard Durand | Extrait vegetal obtenu par un procede d'extraction a l'aide de solvants d'origine vegetale |
US20080292607A1 (en) * | 2005-11-23 | 2008-11-27 | Elizabeth Mazzio | Nutraceutical agent for attenuating the neurodegenerative process associated with Parkinson's disease |
US8962058B2 (en) * | 2005-11-23 | 2015-02-24 | The Coca-Cola Company | High-potency sweetener composition with antioxidant and compositions sweetened therewith |
EP1976391B1 (en) | 2005-12-30 | 2010-10-20 | Cadbury Holdings Limited | Chewing gum composition containing chokeberry |
US20070269576A1 (en) * | 2006-05-18 | 2007-11-22 | Brent Barton | Exotic fruit juice and silver-containing beverage |
JP2007306898A (ja) * | 2006-05-22 | 2007-11-29 | Woc:Kk | 冬虫夏草を用いた機能性食品とその製造方法 |
-
2009
- 2009-05-12 EP EP09006414A patent/EP2260856A1/en not_active Withdrawn
-
2010
- 2010-05-06 JP JP2012509040A patent/JP5612670B2/ja active Active
- 2010-05-06 PT PT10720010T patent/PT2429560T/pt unknown
- 2010-05-06 LT LTEP10720010.7T patent/LT2429560T/lt unknown
- 2010-05-06 ES ES10720010T patent/ES2704025T3/es active Active
- 2010-05-06 DK DK10720010.7T patent/DK2429560T3/en active
- 2010-05-06 EP EP10720010.7A patent/EP2429560B1/en active Active
- 2010-05-06 CA CA2757759A patent/CA2757759C/en active Active
- 2010-05-06 CN CN2010800201956A patent/CN102421446A/zh active Pending
- 2010-05-06 CN CN201310464174.9A patent/CN103845449A/zh active Pending
- 2010-05-06 US US13/320,021 patent/US20120148683A1/en not_active Abandoned
- 2010-05-06 PL PL10720010T patent/PL2429560T3/pl unknown
- 2010-05-06 MX MX2011011860A patent/MX347299B/es active IP Right Grant
- 2010-05-06 WO PCT/EP2010/056190 patent/WO2010130629A1/en active Application Filing
- 2010-05-06 TR TR2018/18784T patent/TR201818784T4/tr unknown
-
2015
- 2015-01-20 US US14/600,837 patent/US10293014B2/en active Active
-
2019
- 2019-02-14 CY CY20191100207T patent/CY1121268T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
US10293014B2 (en) | 2019-05-21 |
LT2429560T (lt) | 2018-12-10 |
CY1121268T1 (el) | 2020-05-29 |
EP2429560B1 (en) | 2018-11-14 |
CA2757759C (en) | 2016-12-20 |
PL2429560T3 (pl) | 2019-04-30 |
JP5612670B2 (ja) | 2014-10-22 |
JP2012526083A (ja) | 2012-10-25 |
MX2011011860A (es) | 2011-12-08 |
ES2704025T3 (es) | 2019-03-13 |
CN102421446A (zh) | 2012-04-18 |
CA2757759A1 (en) | 2010-11-18 |
DK2429560T3 (en) | 2019-02-18 |
MX347299B (es) | 2017-04-21 |
EP2260856A1 (en) | 2010-12-15 |
US20150132418A1 (en) | 2015-05-14 |
WO2010130629A1 (en) | 2010-11-18 |
EP2429560A1 (en) | 2012-03-21 |
PT2429560T (pt) | 2019-02-01 |
CN103845449A (zh) | 2014-06-11 |
US20120148683A1 (en) | 2012-06-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR201818784T4 (tr) | Selenyum İle Kombinasyon Halinde Aronia Sp.'nin Bir Ekstraktını İçeren Bağışık Uyarıcı Terkip | |
WO2009156405A8 (en) | Novel immunoadjuvant flagellin-based compounds and use thereof | |
WO2010149169A3 (en) | Controlled release formulations | |
EP2576578A4 (en) | POLYMORPHES OF 2'-O-FUCOSYLLACTOSE AND MANUFACTURE THEREOF | |
EP3750549A3 (en) | Composition for inducing proliferation or accumulation of regulatory t cells | |
PH12013502192A1 (en) | Antibodies against human angiopoietin 2 | |
MX2013001527A (es) | Nuevas vacunas adyuvantes en base a adyuvantes de orientacion para anticuerpos directamente hacia celulas presentadoras de antigenos. | |
EP2567707A3 (en) | Composition of tumour-associated peptides and related anti-cancer vaccine | |
MX2019009654A (es) | Anticuerpos e inmunoconjugados del receptor 1 de folato y usos de los mismos. | |
MY150855A (en) | Oral compositions containing extracts of zizyphus joazeiro and related methods | |
IN2012DN01920A (tr) | ||
MY157124A (en) | Substituted imidazopyridinyl-aminopyridine compounds | |
MX2011003843A (es) | Incorporacion de adyuvante en inmunonanoterapeuticos. | |
WO2011082273A3 (en) | Substituted pyrrolo-aminopyrimidine compounds | |
WO2011082267A3 (en) | Substituted triazolo-pyrazine compounds | |
WO2010144344A3 (en) | Melanocortin receptor-specific peptides | |
BR112012019190A2 (pt) | composições de cuidado oral. | |
WO2011035205A3 (en) | Antibodies against candida, collections thereof and methods of use | |
MY150829A (en) | Oral compositions containing extracts of myristica fragrans and related methods | |
MX2010003045A (es) | Composiciones de ciclosporina. | |
WO2011082268A3 (en) | Substituted naphthalenyl-pyrimidine compounds | |
WO2009101475A3 (en) | Use of glycosylceramides for enhancing the immune response to antigens | |
EA201171001A1 (ru) | Пептиды трав для вакцины | |
WO2012151279A3 (en) | Induction of il-12 using immunotherapy | |
WO2011130249A3 (en) | Methods and compositions for inhibition of treg cells |